Evaluation of the Efficacy of Combined Therapy of Patients with Diabetic Foot Syndrome Using Αlpha-Lipoic Acid Preparations and Low-Molecular-Weight Heparin
Journal Title: Міжнародний ендокринологічний журнал - Year 2014, Vol 4, Issue 60
Abstract
In this study we have investigated the efficacy of combination of alpha-lipoic acid (ALA) and bemiparin compared to baseline hypoglycemic therpay or additional monotherapy with ALA in patients with diabetic foot syndrome. The study involved 82 patients. Control group included 14 patients who received only hypoglycemic therapy. 37 patients made-up first study group (SG-1) treated with alpha-lipoic acid only in additional to hypoglycemic therapy, first parenterally, then per os. In the second study group (SG-2, 31 patients) we administered combination of ALA and bemiparin. Efficacy criteria were level of transcutaneous partial pressure of oxygen (PtcO2) on the back of the foot and average rating by scale of neuropathy symptoms — NSS. They were determined three times: before treatment, after parenteral administration of ALA and injection of bemiparin (average 12–16 days) and after oral administration of ALA (approximately in 50 days). In patients from SG-1, PtcO2 growth in the first stage has been slower (from 33.11 ± 7.21 mmHg to 36.19 ± 6.45 mmHg) and statistically insignificant (p = 0.054), while in the combination therapy group oxygenation level increased from 30.74 ± 8.50 mmHg up to 39.94 ± 8.14 mmHg, which was significantly better that indicator in the SG-1 (p < 0.05), and baseline (p < 0.01). In the SG-1, PtcO2 at the end of the whole course of treatment has reached 37.65 ± 5.44 mmHg, which was significantly better compared to baseline (p < 0.05). In the SG-2, PtcO2 on the 50th day was 41.61 ± 7.74 mmHg, it is significantly better result as compared to the SG-1 (p < 0.05) and baseline (p < 0.01). In addition, the combination therapy significantly reduced the severity of neuropathy on NSS: from 6.26 ± 1.19 to 3.74 ± 0.62 compared with the control group (from 6.14 ± 0.99 to 5.43 ± 0.90). Also we observed a somewhat better dynamics by NSS compared with ALA monotherapy group, but it did not reach statistical significance.
Authors and Affiliations
M. B. Gorobeiko
Keywords
Related Articles
- EP ID EP226935
- DOI -
- Views 43
- Downloads 0
Cardiovascular Status and Blood Lipids in Childhood-Onset Growth Hormone Deficiency in Young Adults (Literature Review and Own Observations)
The analysis of scientific literature on the features of clinical course of childhood-onset growth hormone deficiency (GHD) in young adults has been carried out. The focus was on the state of lipid metabolism, as well as...
Prevalence of Arterial Hypertension with Space-Occupying Lesions of Adrenal Glands of Various Origins According to Appealability Data
For the period from 2003 to 2008, in RSSPMC of Endocrinology of Republic of Uzbekistan RSSPMC Endocrinology of Republic of Uzbekistan (Tashkent) there were hospitalized 27 patients with arterial hypertension and various...
Laboratory Diagnosis and Management of Gestational Diabetes at the Present Stage
The need for timely and accurate diagnosis of gestational diabetes is determined by a high incidence of pregnancy complications and neonatal morbidity in this pathology. Glycated hemoglobin, which gives an integrated vie...
Anticoagulation Therapy with Bemiparin in Combination Treatment of Patients with Diabetic Peripheral Neuropathy and Latent Ischemia of Lower Limb Tissues
It is known that diabetic peripheral neuropathy as well as microangiopathy increases risk of diabetic foot syndrome development even with preserved patency of main arteries of the lower limbs. In this paper we examined t...
Treatment of Erectile Dysfunction in Type 2 Diabetic Men
Background. One of the most frequent complications of diabetes in men is erectile dysfunction. Phosphodiesterase-5 inhibitors (IPDE-5): sildenafil, vardenafil and tadalafil are the drugs of choice for the treatment of er...